All are risk factors for antituberculosis treatment related hepatotoxicity, EXCEPT:
Risk factors for antituberculosis treatment related hepatotoxicity are CYP2E1 status HLA haplotype associations Female gender Age > 60 Serum albumin < 3.5 mg/L Pre existing chronic liver disease Multidrug regimens Daily Regimens Excess alcohol consumption Ref: Schiff's diseases of liver, E-11, P-727
CYP2E1 status
HLA haplotype associations
Female gender
HBeAg negative hepatitis B